Literature DB >> 16762308

Negative chemical ionization gas chromatography/mass spectrometry to quantify urinary 3-methylhistidine: application to burn injury.

David C Beffa1, Edward A Carter, Xiao-Ming Lu, Yong-Ming Yu, Kathrina Prelack, Robert L Sheridan, Vernon R Young, Alan J Fischman, Ronald G Tompkins.   

Abstract

A rapid method for measuring 3-methylhistidine (3MH) in rat and human urine with higher sensitivity and precision than any previously reported method is described using internal standard [1-(13)C]3MH (M+1) and negative chemical ionization (NCI) gas chromatography/mass spectrometry (GC/MS). Internal standard [1-(13)C]3MH (M+1) was added to rat and human urine samples, hydrolyzed, and absorbed onto cation exchange columns. The column eluent was dried and derivatized for GC/MS analysis. Quantification of 3MH levels was accomplished by monitoring the m/z 204 fragment. The m/z 204 fragment was chosen due to the fragment's abundance and stability as determined by analysis of [methyl-(2)H(3), (18)O(2)]3MH (M+7) and [methyl-(13)C]3MH (M+1) fragmentation patterns under NCI conditions. This method shows excellent linearity (0.9989) over the range studied (0-0.5 mol), high recovery (95.9%), and low coefficient of variation (4.7%). The described method is sensitive enough to detect 6.8 pmol amount of urinary 3MH with a precision of 9.1%. The in vivo utility of this method to quantify urinary 3MH was tested in a burn injury rat model and on urine specimens from pediatric burn patients. Data obtained from the urine of burn-injured rats and pediatric burn patients match previously reported trends and validate the in vivo utility of this method.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762308     DOI: 10.1016/j.ab.2006.03.057

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Tight Glycemic Control With Insulin Does Not Affect Skeletal Muscle Degradation During the Early Postoperative Period Following Pediatric Cardiac Surgery.

Authors:  Jeremy G Fisher; Eric A Sparks; Faraz A Khan; Jamin L Alexander; Lisa A Asaro; David Wypij; Michael Gaies; Biren P Modi; Christopher Duggan; Michael S D Agus; Yong-Ming Yu; Tom Jaksic
Journal:  Pediatr Crit Care Med       Date:  2015-07       Impact factor: 3.624

2.  Brown adipose tissue and its modulation by a mitochondria-targeted peptide in rat burn injury-induced hypermetabolism.

Authors:  Kikuo Yo; Yong-Ming Yu; Gaofeng Zhao; Ali A Bonab; Naoki Aikawa; Ronald G Tompkins; Alan J Fischman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-11-20       Impact factor: 4.310

3.  The contribution of muscle to whole-body protein turnover throughout the course of burn injury in children.

Authors:  Kathrina Prelack; Yong Ming Yu; Maggie Dylewski; Martha Lydon; Robert L Sheridan; Ronald G Tompkins
Journal:  J Burn Care Res       Date:  2010 Nov-Dec       Impact factor: 1.845

4.  Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle loss.

Authors:  M Sheffield-Moore; E L Dillon; K M Randolph; S L Casperson; G R White; K Jennings; J Rathmacher; S Schuette; M Janghorbani; R J Urban; V Hoang; M Willis; W J Durham
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-09-06       Impact factor: 12.910

5.  Use of 1H-nuclear magnetic resonance to screen a set of biomarkers for monitoring metabolic disturbances in severe burn patients.

Authors:  Yong Zhang; Bin Cai; Hua Jiang; Hong Yan; Hao Yang; Jin Peng; Wenyuan Wang; Siyuan Ma; Xiuwen Wu; Xi Peng
Journal:  Crit Care       Date:  2014-07-24       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.